NCT00538356

Brief Summary

Re-hospitalizations or deaths by worsening heart failure are often preceded by distinct trends of clinical parameters such as atrial or ventricular arrhythmia, activity, heart rate variability, or ventricular ectopy. The Home Monitoring™ capability offered by BIOTRONIK active implants has the potential to detect some of these trends early and thus to offer the possibility to intervene in time for prevention of fatal worsening of heart failure. To investigate the predictive value of Home Monitoring parameters, patients with symptomatic heart failure and reduced ejection fraction receiving an implantable cardioverter-defibrillator (ICD) or an ICD in combination with cardiac resynchronization therapy (CRT-D) will be randomized between prospective patient management by Home Monitoring analysis or standard care. The influence of Home Monitoring on the clinical status of heart failure patients will be assessed.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
720

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Jul 2007

Longer than P75 for phase_4

Geographic Reach
6 countries

38 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 1, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 2, 2007

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

December 23, 2014

Status Verified

December 1, 2014

Enrollment Period

4.7 years

First QC Date

October 1, 2007

Last Update Submit

December 19, 2014

Conditions

Keywords

Heart failureRehospitalization:Packer composite scoreHome MonitoringCardiac resynchronization therapyImplantable cardioverter-defibrillator

Outcome Measures

Primary Outcomes (1)

  • Composite Score of death, hospitalization for heart failure, NYHA class and global assessment (Packer Score)

    12 months

Secondary Outcomes (1)

  • Rehospitalizations due to worsening heart failure; Correlation of Home Monitoring values with the clinical status; Incidence and reasons for Home Monitoring based interventions; Home Monitoring workflow analysis

    12 months

Study Arms (2)

Home Monitoring

EXPERIMENTAL

ICD or CRT-D with Home Monitoring feature activated Home Monitoring data will be analyzed regularly and patients will be contacted and scheduled for additional follow-up after predefined events

Device: ICD or CRT-D with Home Monitoring feature activated

Control

ACTIVE COMPARATOR

ICD or CRT-D with Home Monitoring feature deactivated Patients will be treated as per standard of care in each participating clinic

Device: ICD or CRT-D with Home Monitoring feature deactivated

Interventions

Standard care + patient management by Home Monitoring

Also known as: Biotronik Home Monitoring, Home Monitoring Service Center
Home Monitoring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Indication for single chamber ICD, dual chamber ICD or CRT-D
  • Chronic heart failure (≥ 3 months)
  • NYHA Class II or III for 1 month prior to screening
  • LVEF ≤ 35% within 3 months prior to screening
  • Indication for therapy with diuretics
  • Patient informed consent

You may not qualify if:

  • Uncontrolled hypertension
  • NYHA class I or IV
  • Permanent atrial fibrillation
  • Life expectancy \< 1 year
  • Restrictive, infiltrative or hypertrophic cardiomyopathy, constrictive pericarditis, acute myocarditis
  • Severe mitral regurgitation
  • Symptomatic aortic stenosis
  • Tricuspid valve replacement
  • Known drug or alcohol abuse
  • Expected non-compliance
  • Pregnancy
  • Participation in another telemonitoring concept
  • Participation in another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (39)

Sydney Adventist Hospital

Wahroonga, 2076, Australia

Location

Universitätsklinik für Innere Medizin

Innsbruck, A-6020, Austria

Location

Institute of Clinical and Experimental Medicine

Prague, 14021, Czechia

Location

Hospital Na Homolce

Prague, 15030, Czechia

Location

Aalborg Hospital

Aalborg, 9100, Denmark

Location

Århus Universitetshospital, Skejby Sygehus

Århus N, 8200, Denmark

Location

Gentofte Hospital

Hellerup, 2900, Denmark

Location

Odense Universitets Hospital

Odense, 5000, Denmark

Location

Zentralklinik Bad Berka

Bad Berka, 99437, Germany

Location

Herz- und Gefäßklinikum Bad Neustadt GmbH

Bad Neustadt an der Saale, 97616, Germany

Location

Bad Segeberger Kliniken GmbH

Bad Segeberg, 23795, Germany

Location

Vivantes Klinikum Neukölln

Berlin, 04129, Germany

Location

Vivantes Klinikum am Urban

Berlin, 10967, Germany

Location

Universitätsklinikum Charité Campus Benjamin Franklin

Berlin, 12200, Germany

Location

Vivantes Humboldt Klinikum

Berlin, 13509, Germany

Location

Städtische Kliniken Bielefeld

Bielefeld, 22604, Germany

Location

Universitätsklinikum Bonn

Bonn, 53105, Germany

Location

Klinikum Coburg gGmbH

Coburg, 96450, Germany

Location

Klinikum Lippe-Detmold

Detmold, 32756, Germany

Location

Westdeutsches Herzzentrum des Universitätsklinikums Essen

Essen, 45122, Germany

Location

Universitätsklinikum Gießen und Marburg

Giessen, 35392, Germany

Location

Medizinische Hochschule

Hanover, 30625, Germany

Location

Universitätsklinikum des Saarlandes

Homburg/Saar, 66421, Germany

Location

Klinikum St. Georg gGmbH

Leipzig, 04129, Germany

Location

Herzzentrum der Universität Leipzig

Leipzig, 04289, Germany

Location

Universitätsklinik Schleswig-Holstein

Lübeck, 23538, Germany

Location

St. Marienhospital Lünen GmbH

Lünen, 44534, Germany

Location

Klinikum Schwabing, Kardiologie

Munich - Schwabing, Germany

Location

Kardiologische Gemeinschaftspraxis Dr. Mühling

München, 80379, Germany

Location

Stiftsklinik Augustinum, Innere Medizin / Kardiologie

München, 81375, Germany

Location

Klinikum der Universität München Großhadern

München, 81377, Germany

Location

Herzzentrum München-Bogenhausen

München, 81925, Germany

Location

Kardiologische Gemeinschaftspraxis Dr. Predel, Dr. Heinrich

Nordhausen, 99734, Germany

Location

St. Vincenz Krankenhaus GmbH

Paderborn, 33098, Germany

Location

Klinikum Pirna GmbH

Pirna, 01796, Germany

Location

Barzilai Medical Center

Ashkelon, 78306, Israel

Location

Rabin Medical Center

Petah Tikva, 49100, Israel

Location

Chaim Sheba Medical Center

Tel Litwinsky, 52621, Israel

Location

P. Stradins Clinical University Hospital, Latvian Centre of Cardiology

Riga, Latvia

Location

Related Publications (2)

  • Arya A, Block M, Kautzner J, Lewalter T, Mortel H, Sack S, Schumacher B, Sogaard P, Taborsky M, Husser D, Hindricks G; IN-TIME investigators. Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN-TIME study. Eur J Heart Fail. 2008 Nov;10(11):1143-8. doi: 10.1016/j.ejheart.2008.08.004. Epub 2008 Sep 19.

    PMID: 18805053BACKGROUND
  • Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, Brachmann J, Lewalter T, Goette A, Block M, Kautzner J, Sack S, Husser D, Piorkowski C, Sogaard P; IN-TIME study group*. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014 Aug 16;384(9943):583-590. doi: 10.1016/S0140-6736(14)61176-4.

MeSH Terms

Conditions

Ventricular FibrillationTachycardia, VentricularHeart Failure

Interventions

Defibrillators, Implantable

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsTachycardiaCardiac Conduction System Disease

Intervention Hierarchy (Ancestors)

DefibrillatorsElectrodesElectrical Equipment and SuppliesEquipment and SuppliesElectrodes, ImplantedProstheses and Implants

Study Officials

  • Gerhard Hindricks, Prof. Dr.

    Herzzentrum Leipzig, Germany

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2007

First Posted

October 2, 2007

Study Start

July 1, 2007

Primary Completion

March 1, 2012

Study Completion

August 1, 2013

Last Updated

December 23, 2014

Record last verified: 2014-12

Locations